Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label, parallel-group, phase 2 randomized trial which randomizes patients
with isolated resectable colorectal cancer peritoneal metastases to receive preoperative
systematic therapy followed by CRS+HIPEC and postoperative chemotherapy or upfront CRS+HIPEC
followed by postoperative chemotherapy.